Literature DB >> 23561468

Genomic approaches to chronic lymphocytic leukemia.

Ma Reina Improgo1, Jennifer R Brown.   

Abstract

This article discusses recent advances in genomic approaches used to understand chronic lymphocytic leukemia. Tools for analyzing DNA-level lesions are described, data obtained from these various platforms summarized, and the clinical relevance of these findings discussed.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 23561468      PMCID： PMC3615477          DOI： 10.1016/j.hoc.2013.01.001

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN： 0889-8588            Impact factor:   3.722


  57 in total

1.  Oncogenically active MYD88 mutations in human lymphoma.

Authors:  Vu N Ngo; Ryan M Young; Roland Schmitz; Sameer Jhavar; Wenming Xiao; Kian-Huat Lim; Holger Kohlhammer; Weihong Xu; Yandan Yang; Hong Zhao; Arthur L Shaffer; Paul Romesser; George Wright; John Powell; Andreas Rosenwald; Hans Konrad Muller-Hermelink; German Ott; Randy D Gascoyne; Joseph M Connors; Lisa M Rimsza; Elias Campo; Elaine S Jaffe; Jan Delabie; Erlend B Smeland; Richard I Fisher; Rita M Braziel; Raymond R Tubbs; J R Cook; Denny D Weisenburger; Wing C Chan; Louis M Staudt
Journal:  Nature       Date:  2010-12-22       Impact factor: 49.962

2.  Common genetic variation at 15q25.2 impacts on chronic lymphocytic leukaemia risk.

Authors:  Dalemari Crowther-Swanepoel; Maria Chiara Di Bernardo; Krzysztof Jamroziak; Lidia Karabon; Irena Frydecka; Silvia Deaglio; Giovanni D'Arena; Davide Rossi; Gianluca Gaidano; Bianca Olver; Amy Lloyd; Peter Broderick; Luca Laurenti; Zofia Szemraj-Rogucka; Tadeusz Robak; Daniel Catovsky; Richard S Houlston
Journal:  Br J Haematol       Date:  2011-05-09       Impact factor: 6.998

3.  Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Roxane Collins; Sajid Shakhan; Jinghui Li; Edward Peres; Lisa Kujawski; Moshe Talpaz; Mark Kaminski; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Blood       Date:  2011-07-27       Impact factor: 22.113

4.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.

Authors:  Xose S Puente; Magda Pinyol; Víctor Quesada; Laura Conde; Gonzalo R Ordóñez; Neus Villamor; Georgia Escaramis; Pedro Jares; Sílvia Beà; Marcos González-Díaz; Laia Bassaganyas; Tycho Baumann; Manel Juan; Mónica López-Guerra; Dolors Colomer; José M C Tubío; Cristina López; Alba Navarro; Cristian Tornador; Marta Aymerich; María Rozman; Jesús M Hernández; Diana A Puente; José M P Freije; Gloria Velasco; Ana Gutiérrez-Fernández; Dolors Costa; Anna Carrió; Sara Guijarro; Anna Enjuanes; Lluís Hernández; Jordi Yagüe; Pilar Nicolás; Carlos M Romeo-Casabona; Heinz Himmelbauer; Ester Castillo; Juliane C Dohm; Silvia de Sanjosé; Miguel A Piris; Enrique de Alava; Jesús San Miguel; Romina Royo; Josep L Gelpí; David Torrents; Modesto Orozco; David G Pisano; Alfonso Valencia; Roderic Guigó; Mónica Bayés; Simon Heath; Marta Gut; Peter Klatt; John Marshall; Keiran Raine; Lucy A Stebbings; P Andrew Futreal; Michael R Stratton; Peter J Campbell; Ivo Gut; Armando López-Guillermo; Xavier Estivill; Emili Montserrat; Carlos López-Otín; Elías Campo
Journal:  Nature       Date:  2011-06-05       Impact factor: 49.962

5.  Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL.

Authors:  Susan L Slager; Kari G Rabe; Sara J Achenbach; Celine M Vachon; Lynn R Goldin; Sara S Strom; Mark C Lanasa; Logan G Spector; Laura Z Rassenti; Jose F Leis; Nicola J Camp; Martha Glenn; Neil E Kay; Julie M Cunningham; Curtis A Hanson; Gerald E Marti; J Brice Weinberg; Vicki A Morrison; Brian K Link; Timothy G Call; Neil E Caporaso; James R Cerhan
Journal:  Blood       Date:  2010-12-03       Impact factor: 22.113

6.  IRF4 mutations in chronic lymphocytic leukemia.

Authors:  Violaine Havelange; Yuri Pekarsky; Tatsuya Nakamura; Alexey Palamarchuk; Hansjuerg Alder; Laura Rassenti; Thomas Kipps; Carlo M Croce
Journal:  Blood       Date:  2011-07-25       Impact factor: 22.113

7.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

Review 8.  Advances in understanding cancer genomes through second-generation sequencing.

Authors:  Matthew Meyerson; Stacey Gabriel; Gad Getz
Journal:  Nat Rev Genet       Date:  2010-10       Impact factor: 53.242

9.  TP53 mutation and survival in chronic lymphocytic leukemia.

Authors:  Thorsten Zenz; Barbara Eichhorst; Raymonde Busch; Tina Denzel; Sonja Häbe; Dirk Winkler; Andreas Bühler; Jennifer Edelmann; Manuela Bergmann; Georg Hopfinger; Manfred Hensel; Michael Hallek; Hartmut Döhner; Stephan Stilgenbauer
Journal:  J Clin Oncol       Date:  2010-08-09       Impact factor: 44.544

10.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation.

Authors:  Giulia Fabbri; Silvia Rasi; Davide Rossi; Vladimir Trifonov; Hossein Khiabanian; Jing Ma; Adina Grunn; Marco Fangazio; Daniela Capello; Sara Monti; Stefania Cresta; Ernesto Gargiulo; Francesco Forconi; Anna Guarini; Luca Arcaini; Marco Paulli; Luca Laurenti; Luigi M Larocca; Roberto Marasca; Valter Gattei; David Oscier; Francesco Bertoni; Charles G Mullighan; Robin Foá; Laura Pasqualucci; Raul Rabadan; Riccardo Dalla-Favera; Gianluca Gaidano
Journal:  J Exp Med       Date:  2011-06-13       Impact factor: 14.307
View more
  1 in total

1.  Up-regulation of CDK9 kinase activity and Mcl-1 stability contributes to the acquired resistance to cyclin-dependent kinase inhibitors in leukemia.

Authors:  Yuh-Ying Yeh; Rong Chen; Joshua Hessler; Emilia Mahoney; Amy M Lehman; Nyla A Heerema; Michael R Grever; William Plunkett; John C Byrd; Amy J Johnson
Journal:  Oncotarget       Date:  2015-02-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.